DPVP (Resveratrol Analog)
| Code | Size | Price |
|---|
| AG-CR1-3604-M001 | 1 mg | £140.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
-20°C
Storage:
-20°C
Documents
Further Information
Alternate Names/Synonyms:
Resveratrol Analog I; 4-[2-(3,5-Dimethoxyphenyl)-vinyl]pyridine
Appearance:
White to off-white powder.
CAS:
1462947-40-5 | 223386-36-5
EClass:
32160000
Form (Short):
solid
GHS Symbol:
GHS07
Handling Advice:
Keep cool and dry.
Hazards:
H319, H335
InChi:
InChI=1S/C15H15NO2/c1-17-14-9-13(10-15(11-14)18-2)4-3-12-5-7-16-8-6-12/h3-11H,1-2H3/b4-3-
InChiKey:
HXJQPOSPRKZPGS-ARJAWSKDSA-N
Long Description:
Chemical. CAS: 1462947-40-5 | 223386-36-5. Formula: C15H15NO2. MW: 241.3. Anticancer compound. Shown to inhibit progression of prostate cancer cells. Anti-obesity agent. 3T3-L1 adipocyte differentiation and FAS expression inhibitor.
MDL:
MFCD09033676
Molecular Formula:
C15H15NO2
Molecular Weight:
241.3
Package Type:
Vial
Precautions:
P261, P271, P280, P312
Product Description:
Anticancer compound. Shown to inhibit progression of prostate cancer cells. Anti-obesity agent. 3T3-L1 adipocyte differentiation and FAS expression inhibitor.
Purity:
>98% (NMR)
Signal Word:
Warning
SMILES:
COC1=CC(C=CC2=CC=NC=C2)=CC(OC)=C1
Solubility Chemicals:
Soluble in DMSO or methanol. Insoluble in water.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
References
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors: S. Kim, et al.; J. Med. Chem. 45, 160 (2002) | Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells: K.M. Yoo, et al.; Arch. Pharm. 339, 238 (2006) | Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes: S. Rayalam, et al.; Phytother. Res. 22, 1367 (2008) | Resveratrol analog 4-[2-(3,5-dimethoxyphenyl)vinyl]pyridine reduces differentiation of the 3T3-L1 adipocyte: J.T. Hwang, et al.; Pharm. Biol. 51, 96 (2013)